Q3 2025 Management View CEO Bernd Brust opened the call by reporting $41.6 million in total revenue for Q3 2025, with Biologic Safety Testing (BST) contributing $16.3 million (up 7%) and Nucleic Acid ...
Post-Diwali PM2.5 in Delhi hit 488 µg/m³, pushing AQI to 999 in some areas; air purifier demand surged up to 20X, with rapid ...
Discover Novavax's Q3 2025 earnings: partnership-driven strategy, cost savings, increased revenue outlook, and pipeline progress.
Is your pandemic pet struggling to be alone? An L.A. vet shares expert tips on training, tech, and medication to help ease ...
Researchers say remote and hybrid work schedules could increase the nation's fertility rate by making it easier for Americans ...
Data rights groups are warning of privacy violations and risks to vulnerable communities after Abu Dhabi deployed scanners at ...
Reports third quarter revenue of $1.0 billion, GAAP net loss of $ (0.2) billion and GAAP EPS of $ (0.51) Improves 2025 ...
From a tracker that can tell where someone sleeps at night to a device detecting whether they have a mask on or not, India's ...
Melanoma patients who got an mRNA vaccine for the virus saw median survival times double.
A PCR test detects the actual genetic material of the virus and involves a step that amplifies the presence of any material ...